NCT00260585 2026-04-14
Esophageal Cancer Risk Registry
University of Pittsburgh
Recruiting
Clinical Trials
15 trialsNCT06721520 2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3 Recruiting
NCT05252078 2022-12-16
ALTER-E005
Jiangxi Provincial Cancer Hospital
Phase 2 Recruiting
NCT04090554 2021-08-25
CytoSCCAPE
International Agency for Research on Cancer
Phase NA Completed
NCT03962179 2021-08-05
VACStent
University Hospital of Cologne
Phase NA Unknown
NCT04481100 2020-10-14
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT02526095 2020-09-11
FREGAT
University Hospital, Lille
Recruiting
NCT03187314 2020-08-17
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Completed
NCT03011255 2017-08-07
Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT03200691 2017-08-07
Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT01438385 2017-02-20
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Weill Medical College of Cornell University
Unknown
NCT00442507 2015-07-24
OSI3650
Washington University School of Medicine
Phase 2 Terminated
NCT01927016 2015-04-01
FREGAT I
University Hospital, Lille
Completed
NCT00874263 2012-06-22
ASGE-FNDT-1
Mayo Clinic
Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed